Andrew S. Kraft, MD

Associate Vice President for Oncology Programs
Director, University of Arizona Cancer Center

University of Arizona Health Sciences

Andrew S. Kraft, MD, is the associate vice president for oncology programs at the University of Arizona Health Sciences, Sydney E. Salmon endowed chair and director of the University of Arizona Cancer Center (UACC), tenured professor of medicine in the Department of Medicine, Division of Hematology/Oncology and senior associate dean for translational research in the College of Medicine – Tucson.

A nationally recognized prostate cancer physician-scientist and cancer center administrator, at UACC, Dr. Kraft has overall responsibility for the Center’s $35 million research portfolio and oversight of oncology clinical operations in Tucson, in partnership with Banner - University Medicine. He also oversees the development and implementation of the clinical and clinical research operations at the UACC facility in Phoenix in collaboration with Dignity Health/St. Joseph’s Hospital and Medical Center.

An accomplished prostate cancer researcher and developer of novel cancer drugs, Dr. Kraft is the principal investigator for numerous clinical trials aimed at finding new treatments and cures for cancer. His research has continuously been funded since 1985 by the National Cancer Institute. He also has received support from the U.S. Department of Defense and the Prostate Cancer Research Foundation. He has more than 130 publications in peer-reviewed journals.

Recruited to the Medical University of South Carolina (MUSC) in 2004, Dr. Kraft led the Hollings Cancer Center’s efforts to become a National Cancer Institute (NCI) designated Cancer Center. Under Dr. Kraft’s leadership, Hollings attained NCI Cancer Center status in 2009, a distinction shared by only 67 other cancer centers in the United States.

At MUSC, Dr. Kraft served as associate dean for oncology affairs, was a University Distinguished Professor of medicine and biochemistry and molecular biology, and held the William H. Folk, MD, Chair in Experimental Oncology. A practicing clinical oncologist with a clinical research focus on sarcoma and genitourinary cancers, he is board certified in internal medicine and oncology.

Accomplished in developing novel scientific and clinical programs to attack and cure cancer, Dr. Kraft fostered collaboration by establishing committees of fellow scientists and physicians to develop unique research approaches to cancer diagnostics and therapeutics. He is an accomplished fundraiser, responsible for $49 million in philanthropy over five years. He also successfully gained federal support to expand the Hollings Cancer Center Disparities Program.

Prior to his appointment at MUSC, Dr. Kraft was chief of the Division of Medical Oncology at the University of Colorado Health Sciences Center; prior to that, he was associate director of the Division of Hematology/Oncology at the University of Alabama at Birmingham. He received his medical degree from the University of Pennsylvania, completed an internship and residency at The Mount Sinai Hospital in New York, and was first a research associate and then a clinical staff fellow at the National Cancer Institute. Dr. Kraft is an elected member of the Association of American Physicians and the American Society of Clinical Investigation. He also is a member of the American Association for Cancer Research, the American Society of Hematology and the American Society of Biologic Chemists. During his career, he has mentored 37 post-doctoral fellows.